Indian glass vials producers said they are gearing up to meet any potential demand arising from pharmaceutical companies to fill their COVID-19 vaccines and drugs. Health experts globally are ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

We update you on the latest drama surrounding Shane’s Spinraza injection. Secretary Bessent sends message on Walmart price increases due to tariffs How to hard boil eggs without using water ...

Increases in the ratio were significantly associated with gains in motor function, including improved motor skills, hand and arm abilities, and daily living activities, following long-term treatment ...

Scholar Rock Holding Corp (SRRK), with a market capitalization of nearly $3 billion, released its Q1 2025 earnings, reporting an EPS of -0.67 compared to the forecasted -0.66. Despite the slight ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against ...

TORONTO, May 12, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced its financial results for the quarter ended March 31, 2025. The Trust's first quarter ...

I’ve been putting off this column for months, I guess in the hopes that it’d become easier to write. I didn’t want to go public until I knew for sure that everything was going to be all right, hence ...

We recently published a list of Billionaire Glenn Russell Dubin’s 10 Stock Picks with Huge Upside Potential.In this article, we are going to take a look at where Ionis Pharmaceuticals, Inc ...

With the recent launch of TRYNGOLZA and the development of a solid royalty base from partnered drugs like SPINRAZA and WAINUA, Ionis has made the shift to independent commercialization.

With the recent launch of TRYNGOLZA and the development of a solid royalty base from partnered drugs like SPINRAZA and WAINUA, Ionis has made the shift to independent commercialization.